Literature DB >> 2738961

New Joint National Committee recommendations as they affect black hypertensive patients.

K C Ferdinand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2738961      PMCID： PMC2625786     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN： 0027-9684            Impact factor:   1.798


× No keyword cloud information.
  6 in total

1.  Hypertension: a view from Detroit.

Authors:  R B Cubberley
Journal:  J Natl Med Assoc       Date:  1987-03       Impact factor: 1.798

2.  Refractory hypertension: patient types, special problems, and approaches to therapy.

Authors:  J D Wallin
Journal:  J Natl Med Assoc       Date:  1987-03       Impact factor: 1.798

3.  Risk factors in the management of the unique hypertensive patient.

Authors:  J T Wright
Journal:  J Natl Med Assoc       Date:  1987-03       Impact factor: 1.798

4.  Racial differences in the incidence of treatment for end-stage renal disease.

Authors:  S G Rostand; K A Kirk; E A Rutsky; B A Pate
Journal:  N Engl J Med       Date:  1982-05-27       Impact factor: 91.245

Review 5.  Cost effectiveness of labetalol and propranolol in the treatment of hypertension among blacks.

Authors:  G Oster; D M Huse; T E Delea; D D Savage; G A Colditz
Journal:  J Natl Med Assoc       Date:  1987-10       Impact factor: 1.798

6.  Monotherapy with labetalol compared with propranolol. Differential effects by race.

Authors:  W Flamenbaum; M A Weber; F G McMahon; B J Materson; A A Carr; M Poland
Journal:  J Clin Hypertens       Date:  1985-03       Impact factor: 3.738
  6 in total
  1 in total

1.  A new antihypertensive strategy for black patients: low-dose multimechanism therapy.

Authors:  E Saunders; J Neutel
Journal:  J Natl Med Assoc       Date:  1996-03       Impact factor: 1.798
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.